The medication BPC 157 was applied either once, at 1 min after defect creation as an abdominal bath (1 mL/rat) to assess the initial post-injury course, blood vessel presentation, or to assess the subsequent course leading to adhesion formation intraperitoneally once daily, with the first application at 30 min after surgery and the last application 24 h before the assessment
Gunderson L.L., Tepper J.E, 193-1005, 2007
Xylo Research Systems LLC, dba Panda Peptides, is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act
Note: This blog is for educational purposes only and should not be considered medical advice
The value of the product is worth ignoring the scent, and it doesnt last forever